[1]廖远泉.新型冠状病毒核酸检测“假阴性”可能因素探析[J].医学争鸣,2021,(02):66-70.[doi:10.13276/j.issn.1674-8913.2021.02.014]
 LIAO Yuanquan.Possible factors in false negative results of SARS-CoV-2nucleic acid detection[J].,2021,(02):66-70.[doi:10.13276/j.issn.1674-8913.2021.02.014]
点击复制

新型冠状病毒核酸检测“假阴性”可能因素探析

参考文献/References:

[1] ZHU N, ZHANG D, WANG W, et al. A novel coronavirusfrom patients with pneumonia in China, 2019[J]. N Engl JMed, 2020, 382(8):727-733.
[2] CHENG M P, PAPENBURG J, DESJARDINS M, et al.Diagnostic testing for severe acute respiratory syndromerelatedcoronavirus 2: a narrative review[J]. Ann Int Med,2020, 172(11):726-734.
[3] HUANG C, WANG Y, LI X, et al. Clinical features ofpatients infected with 2019 novel coronavirus in Wuhan,China[J]. Lancet, 2020, 395(10223):497-506.
[4] 国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL]. (2020-02-19)
[2020-02-26]. https://China.huanqiu.com/article/9CaKrnKpsZW.
[5] 廖远泉. 寨卡病毒特征及其感染的实验室检测技术研究进展[J]. 中华临床实验室管理电子杂志, 2019, 7(1):11-16.
[6] 廖远泉. 丙型病毒性肝炎病毒感染实验诊断技术及方法学概述[J]. 疾病监测, 2014, 29(10):837-844.
[7] 王凌航. 新型冠状病毒感染的特征及应对[J/OL]. 中华实验和临床感染病杂志(电子版), 2020, 13(1):1-5. http://rs.yiigle.com/CN119284202001/1187849.htm.
[8] 高维寅, 张洪, 罗阳. 新型冠状病毒肺炎核酸检测中的假阴性分析及对策[J]. 国际检验医学杂志, 2020,41(6):641-643, 647.
[9] 钟慧钰, 赵珍珍, 宋兴勃, 等. 新型冠状病毒核酸临床检测要点及经验[J]. 国际检验医学杂志, 2020, 41(5):523-526.
[10] GUAN W, NI Z, HU Y, et al. Clinical characteristics ofcoronavirus disease 2019 in China[J]. N Engl J Med, 2020,382(18):1708-1720.
[11] YANG Y, YANG M H. SHEN C G, et al. Evaluating theaccuracy of different respiratory specimens in the laboratorydiagnosis and monitoring the viral shedding of 2019-nCoVinfections[J]. medRxiv, 2020, Online ahead of print. DOI:10.1101/2020.02.11.2002/493.
[12] 陈炜, 张春阳, 朱颖, 等. 4例新型冠状病毒感染病例咽拭子与痰标本病毒核酸检测的比较[J]. 中国人兽共患病学报, 2020, 45(5):354-358.
[13] 张运洪, 秦维超, 游凤霞, 等. 4种核酸提取方法对3种新型冠状病毒核酸检测试剂检测性能比较与分析[J/OL].检验医学与临床(2020-04-22)
[2020-07-02]. http://kns.cnki.net/kcms/detail/50.1167.r.20200422.1135.002.html.
[14] 郭元元, 王昆, 张宇, 等. 6种国产新型冠状病毒核酸检测试剂检测性能比较与分析[J/OL]. 重庆医学(2020-02-12)
[2020-07-02]. http://kns.cnki.net/kcms/detail/50.1097.r.20200212. 0900.006. html.
[15] 中华人民共和国国家卫生健康委员会. 国家卫生健康委办公厅关于印发新型冠状病毒肺炎防控方案(第五版)的通知(国卫办疾控函
[2020]156号)[EB/OL]. (2020-02-21). https://www.sogou.com/sie?query.
[16] 吴嘉, 汪俊军. 新型冠状病毒实验室检查方法的应用现状及结果解读[J/OL]. 医学研究生学报(2020-04-08)
[2020-07-02]. http://kns.cnki.net/kcms/detail/32.1574.r.20200408.1119.002.html.
[17] 裴银辉, 张杰. 对新型冠状病毒肺炎康复期核酸检测阳性的认识[J]. 医学争鸣, 2020, 11(3):24-27.
[18] 李泉, 张浩, 邓斯予, 等. COVID-19恢复期病毒核酸检测复阳与阴性患者淋巴细胞亚群及形态学特征比较研究[J/OL]. 重庆医学(2020-04-02)
[2020-07-02]. http://kns.cnki.net/kcms/detail/50.1097.R.20200402. 1901.010. html.
[19] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第七版)[J]. 中国医药, 2020, 15(6):801-805.

相似文献/References:

[1]李艳超,白万柱,端川勉.潜在的神经侵袭特性可能是新型冠状病毒肺炎患者呼吸窘迫的原因之一[J].医学争鸣,2020,(01):7.[doi:10.13276/j.issn.1674-8913.2020.01.002 ]
 LI Yanchao,BAI Wanzhu,Tsutomu Hashikawa.Potential neuroinvasion may be one cause of respiratory distress in COVID-19 patients[J].,2020,(02):7.[doi:10.13276/j.issn.1674-8913.2020.01.002 ]
[2]林 真.胆碱酯酶激动剂用于新型冠状病毒肺炎辅助治疗的尝试[J].医学争鸣,2020,(01):15.[doi:10.13276/j.issn.1674-8913.2020.01.004 ]
 LIN Zhen.An attempt to use cholinesterase activators for assistant treatment of COVID-19[J].,2020,(02):15.[doi:10.13276/j.issn.1674-8913.2020.01.004 ]
[3]尚昱志,陈秋霞,方 刚,等.壮医五法预防新型冠状病毒肺炎[J].医学争鸣,2020,(02):7.[doi:10.13276/j.issn.1674-8913.2020.02.002]
 SHANG Yuzhi,CHEN Qiuxia,FANG Gang,et al.Five methods of Zhuang medicine’s epidemic prevention applied to corona virus disease 2019[J].,2020,(02):7.[doi:10.13276/j.issn.1674-8913.2020.02.002]
[4]张佳乐,杨 莉,鲜天才,等.艾灸防控新型冠状病毒肺炎的思路探讨[J].医学争鸣,2020,(02):10.[doi:10.13276/j.issn.1674-8913.2020.02.003]
 ZHANG Jiale,YANG Li,XIAN Tiancai,et al.Thoughts and methods of moxibustion for prevention and control of COVID-19[J].,2020,(02):10.[doi:10.13276/j.issn.1674-8913.2020.02.003]
[5]李代文,蒲 静,赵洁琨,等.五音疗法干预新型冠状病毒肺炎隔离人员情志的理论探讨[J].医学争鸣,2020,(02):15.[doi:10.13276/j.issn.1674-8913.2020.02.004]
 LI Daiwen,PU Jing,ZHAO Jiekun,et al.Theoretical study on five tone therapy for emotions of isolated people during the COVID-19 epidemic[J].,2020,(02):15.[doi:10.13276/j.issn.1674-8913.2020.02.004]
[6]裴银辉,张 杰.对新型冠状病毒肺炎康复期核酸检测阳性的认识[J].医学争鸣,2020,(03):24.[doi:10.13276/j.issn.1674-8913.2020.03.005]
 PEI Yinhui,ZHANG Jie.Connotation behind positive nucleic acid detection results in convalescent COVID-19 patients[J].,2020,(02):24.[doi:10.13276/j.issn.1674-8913.2020.03.005]
[7]柳越冬,陶弘武,倪力强,等.新型冠状病毒肺炎疫情下肛肠外科防控策略及应急流程管理[J].医学争鸣,2020,(03):39.[doi:10.13276/j.issn.1674-8913.2020.03.009]
 LIU Yuedong,TAO Hongwu,NI Liqiang,et al.Prevention and control strategies and emergency operation procedure management in anorectal surgery during COVID-19 pandemic[J].,2020,(02):39.[doi:10.13276/j.issn.1674-8913.2020.03.009]
[8]姚冰洋.新型冠状病毒肺炎疫情防控下卫生政策的伦理思考[J].医学争鸣,2020,(03):49.[doi:10.13276/j.issn.1674-8913.2020.03.011]
 YAO Bingyang.Ethical thinking about health policy based on prevention and control of COVID-19[J].,2020,(02):49.[doi:10.13276/j.issn.1674-8913.2020.03.011]
[9]裴银辉,张 杰.对新型冠状病毒肺炎康复期核酸检测阳性的认识[J].医学争鸣,2020,(04):24.[doi:10.13276/j.issn.1674-8913.2020.03.005]
 PEI Yinhui,ZHANG Jie.Connotation behind positive nucleic acid detection results in convalescent COVID-19 patients[J].,2020,(02):24.[doi:10.13276/j.issn.1674-8913.2020.03.005]
[10]谢静远,杨茂,郭卉.新型冠状病毒肝损伤机制探讨[J].医学争鸣,2021,(预出版):1.[doi:10.1101/2020.02.03.931766]
 XIE Jingyua n,YANG Mao,GUO Hui.Mechanism of liver injury in patients with COVID-19[J].,2021,(02):1.[doi:10.1101/2020.02.03.931766]
[11]廖远泉.SARS-CoV-2核酸检测“假阴性”可能因素探析[J].医学争鸣,2021,(预出版):1.[doi:10.1016/S0140-6736(20)30183-5]
 LIAO Yuanquan.Possible factors in false negative results of SARS-CoV-2 nucleic acid detection[J].,2021,(02):1.[doi:10.1016/S0140-6736(20)30183-5]

备注/Memo

作者简介:廖远泉。副主任检验师。研究方向:病原微生物学及免疫学检验。Tel:18756359306,E-mail:liaoyuanquan@aliyun.com

更新日期/Last Update: 2021-05-01